Litcius/Paper detail

TET2 promotes anti‐tumor immunity by governing G‐MDSCs and CD8+ T‐cell numbers

Shuangqi Li, Jiuxing Feng, Feizhen Wu, Jiabin Cai, Xinyu Zhang, Haikun Wang, Irfete S. Fetahu, Isabella Iwanicki, Dingailu Ma, Tao Hu, Hang Liu, Bingjie Wang, Guo‐Ming Shi, Li Tan, Yujiang Geno Shi

2020EMBO Reports47 citationsDOIOpen Access PDF

Topics & Concepts

CD8Immune systemMyeloid-derived Suppressor CellCancer researchImmunityT cellBiologyAntibodyCytotoxic T cellTumor progressionSuppressorImmunologyCancerGeneticsIn vitroImmune cells in cancerEpigenetics and DNA MethylationHistone Deacetylase Inhibitors Research
TET2 promotes anti‐tumor immunity by governing G‐MDSCs and CD8+ T‐cell numbers | Litcius